PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 111 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2016. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $342,000 | -23.0% | 33,372 | -21.7% | 0.03% | -39.1% |
| Q2 2020 | $444,000 | -87.6% | 42,643 | +42.1% | 0.05% | +12.2% |
| Q3 2017 | $3,592,000 | -48.2% | 30,000 | -62.2% | 0.04% | -60.6% |
| Q2 2017 | $6,939,000 | +1532.7% | 79,400 | +455.2% | 0.10% | +420.0% |
| Q2 2016 | $425,000 | -15.3% | 14,300 | +232.6% | 0.02% | -73.7% |
| Q2 2015 | $502,000 | – | 4,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avalon Global Asset Management LLC | 30,000 | $3,503,000 | 2.29% |
| WEATHERBIE CAPITAL, LLC | 141,123 | $16,476,000 | 1.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $663,918,000 | 1.66% |
| BB BIOTECH AG | 521,991 | $60,942,000 | 1.65% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 317,032 | $37,013,000 | 1.21% |
| Orbimed Advisors | 940,800 | $109,838,000 | 0.81% |
| Perceptive Advisors | 100,000 | $11,675,000 | 0.70% |
| Ghost Tree Capital, LLC | 17,500 | $2,043,000 | 0.66% |
| CAPITAL INTERNATIONAL LTD /CA/ | 90,935 | $10,617,000 | 0.63% |
| Fernwood Investment Management, LLC | 6,800 | $794,000 | 0.62% |